This page is part of the HL7 Version 2 to FHIR (v1.0.0-ballot: STU1 Ballot 1) based on FHIR (HL7® FHIR® Standard) R4. . For a full list of available versions, see the Directory of published versions
Official URL: http://hl7.org/fhir/uv/v2mappings/table-hl70371-to-v2-0371 | Version: 1.0.0-ballot | |||
Active as of 2023-12-19 | Computable Name: TableHL70371ToV20371 | |||
Copyright/Legal: Copyright (c) 2020, HL7 International, Inc., All Rights Reserved. |
This ConceptMap represents a mapping from the HL7 V2 Table HL70371 to the FHIR V2 0371 Value Set.
This ConceptMap represents the mapping from the HL7 V2 Table HL70371 to the FHIR V2 0371 Value Set. See also the FHIR Shorthand or the CSV Source.
HL7 v2 | Condition (IF True, args) | HL7 FHIR | Comments | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Code | Text | Code System | Computable ANTLR | Computable FHIRPath | Narrative | Code | Proposed Extension | Display | Code System | |
F10 | 10% Formalin | HL70371 | F10 | 10% Formalin | http://terminology.hl7.org/CodeSystem/v2-0371 | |||||
C32 | 3.2% Citrate | HL70371 | C32 | 3.2% Citrate | http://terminology.hl7.org/CodeSystem/v2-0371 | |||||
C38 | 3.8% Citrate | HL70371 | C38 | 3.8% Citrate | http://terminology.hl7.org/CodeSystem/v2-0371 | |||||
HCL6 | 6N HCL | HL70371 | HCL6 | 6N HCL | http://terminology.hl7.org/CodeSystem/v2-0371 | |||||
ACDA | ACD Solution A | HL70371 | ACDA | ACD Solution A | http://terminology.hl7.org/CodeSystem/v2-0371 | |||||
ACDB | ACD Solution B | HL70371 | ACDB | ACD Solution B | http://terminology.hl7.org/CodeSystem/v2-0371 | |||||
ACET | Acetic Acid | HL70371 | ACET | Acetic Acid | http://terminology.hl7.org/CodeSystem/v2-0371 | |||||
AMIES | Amies transport medium | HL70371 | AMIES | Amies transport medium | http://terminology.hl7.org/CodeSystem/v2-0371 | |||||
HEPA | Ammonium heparin | HL70371 | HEPA | Ammonium heparin | http://terminology.hl7.org/CodeSystem/v2-0371 | |||||
BACTM | Bacterial Transport medium | HL70371 | BACTM | Bacterial Transport medium | http://terminology.hl7.org/CodeSystem/v2-0371 | |||||
BOR | Borate Boric Acid | HL70371 | BOR | Borate Boric Acid | http://terminology.hl7.org/CodeSystem/v2-0371 | |||||
BOUIN | Bouin's solution | HL70371 | BOUIN | Bouin's solution | http://terminology.hl7.org/CodeSystem/v2-0371 | |||||
BF10 | Buffered 10% formalin | HL70371 | BF10 | Buffered 10% formalin | http://terminology.hl7.org/CodeSystem/v2-0371 | |||||
WEST | Buffered Citrate (Westergren Sedimentation Rate) | HL70371 | WEST | Buffered Citrate (Westergren Sedimentation Rate) | http://terminology.hl7.org/CodeSystem/v2-0371 | |||||
BSKM | Buffered skim milk | HL70371 | BSKM | Buffered skim milk | http://terminology.hl7.org/CodeSystem/v2-0371 | |||||
CARS | Carson's Modified 10% formalin | HL70371 | CARS | Carson's Modified 10% formalin | http://terminology.hl7.org/CodeSystem/v2-0371 | |||||
CARY | Cary Blair Medium | HL70371 | CARY | Cary Blair Medium | http://terminology.hl7.org/CodeSystem/v2-0371 | |||||
CHLTM | Chlamydia transport medium | HL70371 | CHLTM | Chlamydia transport medium | http://terminology.hl7.org/CodeSystem/v2-0371 | |||||
CTAD | CTAD (this should be spelled out if not universally understood) | HL70371 | CTAD | CTAD (this should be spelled out if not universally understood) | http://terminology.hl7.org/CodeSystem/v2-0371 | |||||
ENT | Enteric bacteria transport medium | HL70371 | ENT | Enteric bacteria transport medium | http://terminology.hl7.org/CodeSystem/v2-0371 | |||||
ENT+ | Enteric plus | HL70371 | ENT+ | Enteric plus | http://terminology.hl7.org/CodeSystem/v2-0371 | |||||
JKM | Jones Kendrick Medium | HL70371 | JKM | Jones Kendrick Medium | http://terminology.hl7.org/CodeSystem/v2-0371 | |||||
KARN | Karnovsky's fixative | HL70371 | KARN | Karnovsky's fixative | http://terminology.hl7.org/CodeSystem/v2-0371 | |||||
LIA | Lithium iodoacetate | HL70371 | LIA | Lithium iodoacetate | http://terminology.hl7.org/CodeSystem/v2-0371 | |||||
HEPL | Lithium/Li Heparin | HL70371 | HEPL | Lithium/Li Heparin | http://terminology.hl7.org/CodeSystem/v2-0371 | |||||
M4 | M4 | HL70371 | M4 | M4 | http://terminology.hl7.org/CodeSystem/v2-0371 | |||||
M4RT | M4-RT | HL70371 | M4RT | M4-RT | http://terminology.hl7.org/CodeSystem/v2-0371 | |||||
M5 | M5 | HL70371 | M5 | M5 | http://terminology.hl7.org/CodeSystem/v2-0371 | |||||
MICHTM | Michel's transport medium | HL70371 | MICHTM | Michel's transport medium | http://terminology.hl7.org/CodeSystem/v2-0371 | |||||
MMDTM | MMD transport medium | HL70371 | MMDTM | MMD transport medium | http://terminology.hl7.org/CodeSystem/v2-0371 | |||||
HNO3 | Nitric Acid | HL70371 | HNO3 | Nitric Acid | http://terminology.hl7.org/CodeSystem/v2-0371 | |||||
NONE | None | HL70371 | NONE | None | http://terminology.hl7.org/CodeSystem/v2-0371 | |||||
PAGE | Pages's Saline | HL70371 | PAGE | Pages's Saline | http://terminology.hl7.org/CodeSystem/v2-0371 | |||||
PHENOL | Phenol | HL70371 | PHENOL | Phenol | http://terminology.hl7.org/CodeSystem/v2-0371 | |||||
KOX | Potassium Oxalate | HL70371 | KOX | Potassium Oxalate | http://terminology.hl7.org/CodeSystem/v2-0371 | |||||
EDTK | Potassium/K EDTA | HL70371 | EDTK | Potassium/K EDTA | http://terminology.hl7.org/CodeSystem/v2-0371 | |||||
EDTK15 | Potassium/K EDTA 15% | HL70371 | EDTK15 | Potassium/K EDTA 15% | http://terminology.hl7.org/CodeSystem/v2-0371 | |||||
EDTK75 | Potassium/K EDTA 7.5% | HL70371 | EDTK75 | Potassium/K EDTA 7.5% | http://terminology.hl7.org/CodeSystem/v2-0371 | |||||
PVA | PVA (polyvinylalcohol) | HL70371 | PVA | PVA (polyvinylalcohol) | http://terminology.hl7.org/CodeSystem/v2-0371 | |||||
RLM | Reagan Lowe Medium | HL70371 | RLM | Reagan Lowe Medium | http://terminology.hl7.org/CodeSystem/v2-0371 | |||||
SST | Serum Separator Tube (Polymer Gel) | HL70371 | SST | Serum Separator Tube (Polymer Gel) | http://terminology.hl7.org/CodeSystem/v2-0371 | |||||
SILICA | Siliceous earth, 12 mg | HL70371 | SILICA | Siliceous earth, 12 mg | http://terminology.hl7.org/CodeSystem/v2-0371 | |||||
NAF | Sodium Fluoride | HL70371 | NAF | Sodium Fluoride | http://terminology.hl7.org/CodeSystem/v2-0371 | |||||
FL100 | Sodium Fluoride, 100mg | HL70371 | FL100 | Sodium Fluoride, 100mg | http://terminology.hl7.org/CodeSystem/v2-0371 | |||||
FL10 | Sodium Fluoride, 10mg | HL70371 | FL10 | Sodium Fluoride, 10mg | http://terminology.hl7.org/CodeSystem/v2-0371 | |||||
NAPS | Sodium polyanethol sulfonate 0.35% in 0.85% sodium chloride | HL70371 | NAPS | Sodium polyanethol sulfonate 0.35% in 0.85% sodium chloride | http://terminology.hl7.org/CodeSystem/v2-0371 | |||||
HEPN | Sodium/Na Heparin | HL70371 | HEPN | Sodium/Na Heparin | http://terminology.hl7.org/CodeSystem/v2-0371 | |||||
EDTN | Sodium/Na EDTA | HL70371 | EDTN | Sodium/Na EDTA | http://terminology.hl7.org/CodeSystem/v2-0371 | |||||
SPS | SPS(this should be spelled out if not universally understood) | HL70371 | SPS | SPS(this should be spelled out if not universally understood) | http://terminology.hl7.org/CodeSystem/v2-0371 | |||||
STUTM | Stuart transport medium | HL70371 | STUTM | Stuart transport medium | http://terminology.hl7.org/CodeSystem/v2-0371 | |||||
THROM | Thrombin | HL70371 | THROM | Thrombin | http://terminology.hl7.org/CodeSystem/v2-0371 | |||||
FDP | Thrombin NIH; soybean trypsin inhibitor (Fibrin Degradation Products) | HL70371 | FDP | Thrombin NIH; soybean trypsin inhibitor (Fibrin Degradation Products) | http://terminology.hl7.org/CodeSystem/v2-0371 | |||||
THYMOL | Thymol | HL70371 | THYMOL | Thymol | http://terminology.hl7.org/CodeSystem/v2-0371 | |||||
THYO | Thyoglycollate broth | HL70371 | THYO | Thyoglycollate broth | http://terminology.hl7.org/CodeSystem/v2-0371 | |||||
TOLU | Toluene | HL70371 | TOLU | Toluene | http://terminology.hl7.org/CodeSystem/v2-0371 | |||||
URETM | Ureaplasma transport medium | HL70371 | URETM | Ureaplasma transport medium | http://terminology.hl7.org/CodeSystem/v2-0371 | |||||
VIRTM | Viral Transport medium | HL70371 | VIRTM | Viral Transport medium | http://terminology.hl7.org/CodeSystem/v2-0371 |
Mapping from HL70371 to http://terminology.hl7.org/CodeSystem/v2-0371
ACTIVE (not intended for production usage). Published on 2023-12-19 by HL7 International / Orders and Observations (HL7 Orders and Observations Workgroup: http://www.hl7.org/Special/com..., Keith W. Boone: kboone@ainq.com, Rob Hausam: rrhausam@gmail.com). Copyright (c) 2020, HL7 International, Inc., All Rights Reserved.
This ConceptMap represents a mapping from the HL7 V2 Table HL70371 to the FHIR V2 0371 Value Set.
Group 1Mapping from unspecified code system
to unspecified code system